Ulti_1170x120_5-11-20

Video Forum: George Rafferty, AmerisourceBergen

Video Forum: George Rafferty, AmerisourceBergen

In this week’s Video Forum, George Rafferty, president of corporate partnerships at AmerisourceBergen, discusses the drug wholesaler’s innovative go-to-market strategy. The new model aims to provide customers with top-notch day-to-day support, while at the same time fostering more strategic, long-term relationships.

WBA, AmerisourceBergen thrive on symbiosis

WBA, AmerisourceBergen thrive on symbiosis

Walgreens Boots Alliance and AmerisourceBergen earlier this month took the next but far from final step in their long-standing partnership, when the former agreed to sell the latter most of Alliance Healthcare. Valued at some $6.5 billion, the deal will bring AmerisourceBergen’s pharmaceutical distribution and health care solutions business to 13 countries, mostly in Europe,

Walgreens plans tech-enabled startup

Walgreens plans tech-enabled startup

DEERFIELD, Ill.— Walgreens Boots Alliance has shifted into high gear since the start of 2021. Building on a foundation that it painstakingly laid in recent years, the company has unleashed a salvo of initiatives designed to buttress its central role in health care and retailing. Following the realignment of its partnership with AmerisourceBergen — a

Pessina discusses implications of AmerisourceBergen deal

Pessina discusses implications of AmerisourceBergen deal

DEERFIELD, Ill. — Walgreens Boots Alliance and AmerisourceBergen yesterday took the next but far from final step in their long-standing partnership, when the former agreed to sell the latter most of Alliance Healthcare. Valued at some $6.5 billion, the deal will bring AmerisourceBergen’s pharmaceutical distribution and health care solutions business to 13 countries, mostly in

Video Forum: George Coleman, CVS Health

Video Forum: George Coleman, CVS Health

George Coleman, senior vice president of merchandising at CVS Health, tells this week’s Video Forum about the company’s evolving strategy at a turning point in its history. Coleman, who has just been named Merchant of the Year by Chain Drug Review, comments on the transition in leadership under way at CVS Health, the company’s omnichannel

Video Forum: Steve Mister, CRN

Video Forum: Steve Mister, CRN

  In this week’s Video Forum, Steve Mister, president and chief executive officer of the Council for Responsible Nutrition, discusses recent developments in the dynamic vitamin and nutritional supplements category. The topics he speaks to include the performance of the business during the COVID-19 pandemic, CRN’s response to the American Medical Association’s call for greater

Video Forum: Nicholas Hall, Nicholas Hall Group of Cos.

Video Forum: Nicholas Hall, Nicholas Hall Group of Cos.

  Nicholas Hall is one of the world’s leading experts on consumer health care. In this week’s Video Forum, Hall, executive chairman and creative solutions director at the Nicholas Hall Group of Cos., analyzes the trends shaping the O-T-C business. The impact of e-commerce, sources of innovation, and emerging growth categories are among the topics

Video Forum: Dan Leonard, Association for Accessible Medicines

Video Forum: Dan Leonard, Association for Accessible Medicines

  Dan Leonard, longtime leader of the National Pharmaceutical Council who became CEO of the Association for Accessible Medicines in September, discusses the impact of generic medications on health care, and the challenges and opportunities facing the industry. Among the issues addressed are generics’ role in treating COVID-19 patients, the emergence of biosimilars, and the

Critical issues in retail pharmacy

Critical issues in retail pharmacy

Key leaders in community pharmacy recently assembled for a roundtable sponsored by Chain Drug Review to discuss the profession’s impact on health care during the COVID-19 outbreak and beyond. In these highlights from the meeting, panelists from the retailing, pharmaceutical manufacturing and technology sides of the business address the industry’s response to the pandemic, the

1 2 3 14